Ustekinumab as induction and maintenance therapy for ulcerative colitis – national extended follow-up and a review of the literature-Reference-Cited by-同舟云学术

Ustekinumab as induction and maintenance therapy for ulcerative colitis – national extended follow-up and a review of the literature

Author:

Chetwood JD.¹²,Gupta S.³,Subramaniam K.³⁴,De Cruz P.⁵,Moore G.⁶⁷,An YK.⁸,Connor SJ.⁹,Kermeen M.¹,Paramsothy S.¹²¹⁰¹¹,Leong RW.¹²¹⁰¹¹

Affiliation:

1. Department of Gastroenterology and Liver Services, Concord Repatriation General Hospital, Sydney, Australia

2. Concord Clinical School, University of Sydney, Sydney, Australia

3. Gastroenterology and Hepatology Unit, The Canberra Hospital, Canberra, Australian Capital Territory, Australia

4. ANU Medical School, Australian National University, Canberra, Australian Capital Territory, Australia

5. Department of Gastroenterology, Austin Hospital, Melbourne, VIC, Australia

6. Department of Gastroenterology, Monash Health, Melbourne, VIC, Australia

7. School of Clinical Sciences, Monash University, Clayton, VIC, Australia

8. Department of Gastroenterology, Mater Hospital, Brisbane, QLD, Australia

9. Department of Gastroenterology and Hepatology, Liverpool Hospital, Sydney, NSW, Australia

10. Department of Gastroenterology, Macquarie University Hospital, Sydney, NSW, Australia

11. Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

Reference28 articles.